Shares in WuXi Biologics (Cayman) Inc rose as much as 39 percent in their first day of trade in Hong Kong, as investors that couldn’t buy into the initial public offering jostled for a piece of the fast-growing business.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
